Phosphodiesterases as therapeutic targets

Urology. 2003 Apr;61(4):685-91. doi: 10.1016/s0090-4295(02)02439-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Erectile Dysfunction / drug therapy
  • Forecasting
  • Humans
  • Kidney Diseases / drug therapy
  • Male
  • Penis / enzymology
  • Penis / metabolism
  • Phosphodiesterase Inhibitors / pharmacokinetics
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Phosphoric Diester Hydrolases / genetics
  • Phosphoric Diester Hydrolases / metabolism
  • Phosphoric Diester Hydrolases / physiology*
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / drug therapy
  • Substrate Specificity
  • Tissue Distribution
  • Urinary Incontinence / drug therapy
  • Urinary Retention / drug therapy
  • Urinary Retention / etiology
  • Urologic Diseases / drug therapy

Substances

  • Phosphodiesterase Inhibitors
  • Phosphoric Diester Hydrolases